Page last updated: 2024-09-03

geraniin and 3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one

geraniin has been researched along with 3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one in 2 studies

Compound Research Comparison

Studies
(geraniin)
Trials
(geraniin)
Recent Studies (post-2010)
(geraniin)
Studies
(3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one)
Trials
(3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one)
Recent Studies (post-2010) (3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one)
9416620814191
110720814191

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ito, H1
Hatano, T; Ishimoto, H; Ito, H; Myojin, Y; Shibata, M; Sugimoto, Y; Tai, A1

Reviews

1 review(s) available for geraniin and 3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one

ArticleYear
Metabolites of the ellagitannin geraniin and their antioxidant activities.
    Planta medica, 2011, Volume: 77, Issue:11

    Topics: Animals; Antioxidants; Biphenyl Compounds; Chromatography, High Pressure Liquid; Coumarins; Free Radical Scavengers; Geranium; Glucosides; Hydrolyzable Tannins; Intestinal Mucosa; Intestines; Magnetic Resonance Spectroscopy; Metabolic Networks and Pathways; Picrates; Pyrones; Rats

2011

Other Studies

1 other study(ies) available for geraniin and 3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one

ArticleYear
In vivo anti-inflammatory and antioxidant properties of ellagitannin metabolite urolithin A.
    Bioorganic & medicinal chemistry letters, 2011, Oct-01, Volume: 21, Issue:19

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Coumarins; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Discovery; Drug Evaluation, Preclinical; Edema; Free Radical Scavengers; Glucosides; Glucuronides; Humans; Hydrolyzable Tannins; Lythraceae; Mice; Mice, Inbred ICR; Rats

2011